Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response

Area of Science:

• Hepatology
• Oncology
• Immunology

Background:

• Hepatocellular carcinoma (HCC) is frequently associated with Hepatitis C virus (HCV) infection.
• The molecular mechanisms linking HCV infection to HCC development are not fully understood.
• Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is an emerging negative regulator of immunity involved in inflammation and tumorigenesis.

Purpose of the Study:

• To investigate the role of TIPE2 in the development of HCV-induced HCC.
• To elucidate the molecular interaction between HCV proteins and TIPE2.

Main Methods:

• Western blot analysis of TIPE2 expression in HCC and adjacent tissues from HCV-positive patients.
• Immunoprecipitation and immunofluorescence assays to study TIPE2 interaction with HCV non-structural proteins.
• In vitro cell line studies and in vivo nude mouse models to assess tumorigenesis upon TIPE2 modulation.

Main Results:

• TIPE2 expression was significantly lower in HCC tissues compared to paracarcinoma tissues.
• HCV non-structural protein NS5A directly interacted with TIPE2, leading to its degradation.
• TIPE2 downregulation by NS5A increased genomic DNA damage, promoted cell proliferation, and enhanced tumorigenesis in vivo.
• TIPE2 overexpression exhibited opposite effects, suppressing tumorigenesis.

Conclusions:

• NS5A-mediated degradation of TIPE2 contributes to genomic instability and the development of HCV-associated HCC.
• TIPE2 represents a potential novel therapeutic target for treating HCV-induced liver cancer.